[On renal excretion of sodium 4-iodo-5-methylpyrazole-3-carboxylate-131I (author's transl)].
Sodium 4-iodo-5-methylpyrazole-3-carboxylate-131I(IMPC-131I) was synthesized by isotope exchange with Na 131I in the molten state to evaluate its potential usefulness as a renal function and/or imaging agent. Tissue distribution and clearance characteristics of IMPC-131I are described. Tissue distribution experiments in rats indicated a very high renal concentration of radioactivity following intravenous administration. At 5 min the kidney took up 27.8% of the injected dose (16.1% dose per gram) and the total activity in the kidney still accounted for 9.8% of the injected dose at 30 min, with only 1.2% localizing in the liver. The ratios for kidney-to-liver in the concentration of IMPC-131I were always higher than those of hippuran -131I throughout the period of the experiment. Within 24 hr, 78.6% of the injected dose were excreted in the urine. The autoradiographic and the scannographic studies were also performed. The present results suggest that IMPC-131I has potential as a new agent for both funciton and imaging studies of the kidney.
D000818:Animals; D001345:Autoradiography; D007457:Iodine Radioisotopes; D007668:Kidney / Q000378:metabolism*; D011720:Pyrazoles / Q000378:metabolism*; D011866:Radioisotope Renography; D051381:Rats
D007457:Iodine Radioisotopes; D011720:Pyrazoles